Increased expression of IL-17RD in GBM tissue was associated with higher survival rates compared to patients with low IL-17RD expression, while the 3-year OS rates in patients with high IL-17RD were approximately 2,7 fold higher than in the low IL-17RD group (19.5% vs. 7.2%, respectively) [86]. The gene discussed is IL17RD; the disease is glioblastoma.